Vertaling van "atrial fibrillation " (Nederlands → Frans) :

TERMINOLOGIE

fibrillator
fibrillateur

atriale fibrillatie en flutter
fibrillation auriculaire et flutter

idiopathische neonatale atriale flutter
flutter auriculaire idiopathique du nouveau-né

atriale stilstand
syndrome de cardiomyopathie auriculaire-bloc cardiaque

premature atriale contractie
contraction auriculaire prématurée

paroxysmale atriale flutter
flutter auriculaire paroxystique

atriale tachycardie
tachycardie auriculaire

atriale trigeminie
trigéminisme auriculaire

snelle atriale fibrillatie
fibrillation auriculaire rapide

atriale retractor
retracteur atrial

IN-CONTEXT TRANSLATIONS

Lip GYH, Nieuwlaat R, Pisters R et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation.
predict warfarin-associated hemorrhage. The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.

Bespreking van: van Walraven C, Hart RG, Conolly S et al. Effect of age on stroke prevention therapy in patients with atrial fibrillation: the Atrial Fibrillation Investigators.
Dunn A. Oral anticoagulant therapy safely prevented stroke in older patients with atrial fibrilllation. Evid Based Med 2009; 14:140.

Friberg L, Rosenqvist M, Lip GY. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study.
Olesen JB, Lip GYH, Hansen ML et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study.

Naar Camm AJ en Savelieva I. Some patients with paroxysmal atrial fibrillation should carry flecainide or propafenone to self treat.
D’après Camm AJ et Savelieva I. Some patients with paroxysmal atrial fibrillation should carry flecainide or propafenone to self treat.

2012.2332)], met als titel " Rate versus rhythm control in atrial fibrillation.
2012.2332)], intitulé " Rate versus rhythm control in atrial fibrillation.

Garcia D en Hylek E: Stroke prevention in elderly patients with atrial fibrillation.
Garcia D et Hylek E: Stroke prevention in elderly patients with atrial fibrillation.

Olesen JB, Lip GYH, Hansen ML et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study.
Lip GYH, Nieuwlaat R, Pisters R et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation.

Aguilar MI, Hart R. Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks.
Search Date February 2009. [http ...]

Aguilar MI, Hart R. Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks. Cochrane Database of Systematic Reviews 2005, Issue.
Cochrane Database of Systematic Reviews 2011, Issue 12.

Hart RG, Pearce LA, Aguilar MI. Meta-analysis: anti-thrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation.
Aguilar MI, Hart R. Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks.